The analysis of lymphocyte subsets using fluorochrome labelled monoclonal antibodies and flow cytometry is now routine clinical practice. Clinical laboratories require a rapid and reliable method that provides both accuracy and precision. Various procedures have consequently been evaluated for the preparation of samples before flow cytometric analysis. These include isolation of lymphocytes on a discontinuous gradient before analysis and whole blood lysis techniques in which the lymphocytes are labelled either before or after red cell lysis. Both directly and indirectly labelled fluorescent polyclonal or monoclonal antibodies have been used. All of these approaches have been reviewed.' Furthermore, several factors including storage time,2 holding temperature,"7 choice of anticoagulant5 and transport media8 have been 337 shown to affect the yield of T lymphocytes from blood samples. The hours.
PRE-LYSIS METHOD
Whole blood was lysed by mixing 1 ml with 50 ml of a lysing reagent (8-26 g/l ammonium chloride, 0-84 g/l sodium bicarbonate, and 0 037 g/l tetra sodium EDTA) for 10 minutes at room temperature. All samples were then centrifuged at 600 x g for 10 minutes, the supernate removed, and the cell pellet resuspended in 1 ml of Hanks's Balanced Salt Solution, Ca"++/Mg++ free (Gibco, the Dexter Corporation). On all occasions the pellet was resuspended in an appropriate volume to ensure a cell concentration of about 2 x 10'/ml. To tubes containing 10 M1 of each monoclonal antibody, 50 jul of the lysed cell suspension was added. The samples were vortexed, incubated for 20 minutes at 4°C, followed by the addition of4 ml of 10% formaldehyde fixative (May and Baker, Australia) to each tube while vortexing. Samples were held for 10 minutes at 4°C and then centrifuged for 10 minutes at 600 x g. The supernate was removed and the cell pellet resuspended in 150 p1 of 01iM phosphate buffer (pH 7-2-7 4) containing 1% sodium azide. Samples were held at 4°C and analysed within 24 hours.
All samples were analysed on a Coulter EPICS V flow cytometer (Coulter, Hialeah, Florida) using a 5 watt argon laser with an output of 350 mW at 488 nm. The lymphoid population was gated using forward angle light scatter (FALS) and 900 light scatter (900 LS).
For each monoclonal antibody evaluated, 3-5 x I03 lymphocytes were analysed.
To determine the precision and reproducibility of both methods, intrarun and interrun analysis were undertaken. For each method, one sample was separately processed five times and each analysed five times for CD4 positivity.
The osmolality was determined using the freezing point depression method on an Advanced Digimatic Osmometer model 3D 11 (Advanced Instruments, Neeham Heights, Massachusetts).
All percentages of positively staining lymphocytes were appropriately adjusted to correct for both non-leucocyte events in the gated population (not stained by CD45; HLe-1, Becton-Dickinson) and monocyte contamination (stained by CD 14; Leu-M3, BectonDickinson). All results were expressed in absolute numbers derived from the lymphocyte count, which was determined on a Coulter S IV' cell counter (Coulter, Hialeah, Florida).
Comparisons of lysing reagent adhering to the top of the sample tube, even after mixing, was observed to be the cause. The delivery system of the latest Q-Prep model (not used in this study) has been modified to ensure that the correct volume of reagents is dispensed.
The time required for flow cytometric analysis was almost doubled due to the decrease in final cell concentration. This can be avoided by simply adding a centrifugation step and resuspending the cell pellet in a smaller volume, but this will increase the overall specimen processing time and introduce a potential step for cell loss.
The We believe that the Q-Prep workstation is potentially useful for the rapid preparation of lymphocytes for immunofluorescence analysis. The system has several advantages, including standardisation of preparation, a potentially reduced biohazard risk (due to the decreased number of manipulative steps) compared with conventional procedures, and substantially reduced labour costs. Several potential disadvantages, however, also need to be considered. Not all monoclonal antibodies can be used with the system; significant differences in the incidence of positive cells can be shown compared with established manual whole blood techniques; and the minimum time required to render cells biologically safe needs to be established. Further refinement in the technique will no doubt nullify some of these preliminary findings.
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